Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells

• Published in: Biochimica et biophysica acta. Molecular cell research Vol. 1866; no. 4; pp. 673 - 685
• Main Authors: Navarro-Corcuera, Amaia, López-Zabalza, María J., Martínez-Irujo, Juan J., Álvarez-Sola, Gloria, Ávila, Matías A., Iraburu, María J., Ansorena, Eduardo, Montiel-Duarte, Cristina
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2019
• Subjects: AGAP2; Collagen type I; Hepatic fibrosis; Hepatic stellate cells; TGFβ1; Hepatic fibrosis; AGAP2; COL-I; AP-1; ECM; FAK; TGFR2; TGFβ1; Collagen type I; PEI; HSC; Hepatic stellate cells; ERK
• ISSN: 0167-4889; 1879-2596
• DOI: 10.1016/j.bbamcr.2019.01.008

Liver damage induces hepatic stellate cells (HSC) activation, characterised by a fibrogenic, proliferative and migratory phenotype. Activated HSC are mainly regulated by transforming growth factor β 1 (TGFβ1), which increases the production of extracellular matrix proteins (e.g. collagen-I) promoting the progression of hepatic fibrosis. AGAP2 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2) is a GTPase/GTP-activating protein involved in the actin remodelling system and receptor recycling. In the present work the role of AGAP2 in human HSC in response to TGFβ1 was investigated. LX-2 HSC were transfected with AGAP2 siRNA and treated with TGFβ1. AGAP2 knockdown prevented to some extent the proliferative and migratory TGFβ1-induced capacities of LX-2 cells. An array focused on human fibrosis revealed that AGAP2 knockdown partially prevented TGFβ1-mediated gene expression of the fibrogenic genes ACTA2, COL1A2, EDN1, INHBE, LOX, PDGFB, TGFΒ12, while favored the expression of CXCR4, IL1A, MMP1, MMP3 and MMP9 genes. Furthermore, TGFβ1 induced AGAP2 promoter activation and its protein expression in LX-2. Moreover, AGAP2 protein levels were significantly increased in liver samples from rats with thioacetamide-induced fibrosis. In addition, AGAP2 silencing affected TGFβ1-receptor 2 (TGFR2) trafficking in U2OS cells, blocking its effective recycling to the membrane. AGAP2 silencing in LX-2 cells prevented the TGFβ1-induced increase of collagen-I protein levels, while its overexpression enhanced collagen-I protein expression in the presence or absence of the cytokine. AGAP2 overexpression also increased focal adhesion kinase (FAK) phosphorylated levels in LX-2 cells. FAK and MEK1 inhibitors prevented the increase of collagen-I expression caused by TGFβ1 in LX-2 overexpressing AGAP2. In summary, the present work shows for the first time, that AGAP2 is a potential new target involved in TGFβ1 signalling, contributing to the progression of hepatic fibrosis. [Display omitted] •AGAP2 mediates TGFβ1-induced viability, proliferative and migratory effects in HSC.•AGAP2 is involved in the fibrogenic gene expression profile induced by TGFβ1 in HSC.•TGFβ1 up-regulates AGAP2 promoter activity and protein expression in HSC.•AGAP2 participates in the trafficking of the TGFR2 after TGFβ1 stimulation.•AGAP2-mediated effect of TFGβ on collagen I expression requires FAK and ERK activity.